ARIADNE Clinical Trial
Part of paid clinical trials in Manhasset, New York.
- Sponsor
- Stavros E Mountantonakis
- Study ID
- NCT06747091
- Status
- Recruiting
Conditions
- Persistent Atrial Fibrillation
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Catheter Ablation — PROCEDUREThis is a prospective randomized clinical trial. Patients will undergo catheter ablation for persistent AF using a lattice-tip catheter that can switch between RFA and PFA energy. Enrolled patients will be randomized to one of three ablation strategies:
Study Details
A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.
Key Dates
- Start date
- Mar 18, 2025
- Status verified
- Sep 2025
- Primary completion
- Dec 1, 2026
- Completion
- Mar 1, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: PVI using PFA energyPulmonary vein isolation using PFA energy
- Active Comparator: PVI and posterior wall isolation using PFA energyPulmonary vein isolation and posterior wall isolation using PFA energy
- Active Comparator: PVI and posterior wall isolation (PFA) and mitral isthmus ablation using RFA or PFA energy.Pulmonary vein isolation and posterior wall isolation (PFA) and mitral isthmus ablation using RFA or PFA energy.
Primary Outcome Measure
Percent of subjects free from primary effectiveness failure [ Time Frame: 12 Months ]
Central Contacts
- Kristie Coleman, MPH, RN2124346500
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| North Shore University Hospital | Manhasset | New York | 11030 | Salome Reddy James Gabriels, MD (SUB_INVESTIGATOR) |
| Long Island Jewish Medical Center | New Hyde Park | New York | 11040 | Charell Brinkley Haisam Ismail, MD (SUB_INVESTIGATOR) |
| Kristie Coleman | New York | New York | 10075 | Stavros E Mountantonakis, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Manhasset, NY
Related Studies
- Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial FibrillationRecruiting · Heart Rhythm Clinical and Research Solutions, LLC · Birmingham, Alabama
- ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation PatientsRecruiting · Vivek Reddy · Jonesboro, Arkansas
- Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation SystemRecruiting · Boston Scientific Corporation · Mobile, Alabama
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)Recruiting · Medtronic Cardiac Ablation Solutions · Birmingham, Alabama